1[1]Vilcheze C,Morbidoni HR,Weisbrod TR,et al.Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis[J].J Bacteriol,2000,182(14):4059-4067.
2[2]Slayden RA,Barry CE.The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis[J].Microbes Infect,2000,2(6):659-669.
3[3]Lee H,Cho SN,Bang HE,et al.Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea[J].Int J Tuberc Lung Dis,2000,4(5):441-7.
4[4]Kiepiela P,Bishop KS,Smith AN,et al.Genomic mutations in the katG,inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal,South Africa[J].Tuber Lung Dis,2000,80(1):47-56.
5[5]Mdluli K,Slayden RA,Zhu Y,et al.Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid[J].Science,1998,280(5369):1607-1610.
6[6]Telenti A,Imboden P,Marchesi F,et al.Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis[J].Lancet,1993,341(8846):647-650.
7[7]Jin DJ,Gross CA.Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance[J].J Mol Biol,1988,202(1):45-58.
8[8]Cheng SJ,Thibert L,Sanchez T,et al.pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis:spread of a monoresistant strain in Quebec,Canada[J].Antimicrob Agents Chemother,2000,44(3):528-532.
9[9]Karunakaran P,Davies J.Genetic antagonism and hypermutability in Mycobacterium smegmatis[J].J Bacteriol,2000,182(12):3331-3335.
10[10]Taniguchi H,Chang B,Abe C,et al.Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system[J].J Bacteriol,1997,179(15):4795-4801.
9Drobniewski FA, Watterson SA, Wilson SM, et al. A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis[J]. J Med Microbiol,2000, 49 (3): 271-278.
10Chaves F, Alonso-Sanz M, Rebollo MJ, et al.rpoB muta- tions as an epidemiologic marker in rifampin-resistant Myco- bacterium tuberculosis[J].Int J Tuberc Lung Dis, 2000, 4 ( 8 ): 765-770.
